Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 AUD | -15.25% | -20.63% | -16.67% |
Feb. 25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Jan. 19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Sales 2022 | 446K 294K | Sales 2023 | 149K 98.39K | Capitalization | 13.88M 9.15M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.32M | Net income 2023 | -3M -1.98M | EV / Sales 2022 | 37.7 x |
Net cash position 2022 | 6.34M 4.18M | Net cash position 2023 | 2.99M 1.97M | EV / Sales 2023 | 72.9 x |
P/E ratio 2022 |
-6.84
x | P/E ratio 2023 |
-4.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.93% |
1 day | -15.25% | ||
1 week | -20.63% | ||
Current month | -20.63% | ||
1 month | -16.67% | ||
3 months | -10.71% | ||
6 months | -13.79% | ||
Current year | -16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Grogan
CEO | Chief Executive Officer | - | 23-08-27 |
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sarah Driessens
LAW | General Counsel | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Guthrie
BRD | Director/Board Member | - | 21-04-25 |
Alex Ding
CHM | Chairman | - | 23-05-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.05 | -15.25% | 111,789 |
24-06-06 | 0.059 | 0.00% | 29,500 |
24-06-04 | 0.059 | 0.00% | 30,177 |
24-06-03 | 0.059 | -6.35% | 20,577 |
Delayed Quote Australian S.E., June 06, 2024 at 11:46 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.67% | 6.63M | |
+10.39% | 36.87B | |
-.--% | 11.53B | |
-10.13% | 7.07B | |
+3.68% | 6.61B | |
-5.39% | 5.92B | |
-6.59% | 5.65B | |
-0.38% | 5.42B | |
+36.15% | 5.38B | |
-6.16% | 4.85B |
- Stock Market
- Equities
- BGT Stock